Sign inJoin waitlistJoin the waitlist

Junne Kamihara

Director, Pediatric Cancer Genetic Risk Program · Mass General Brigham

Credentials: · · ·

History

Ocular Oncology Center · Mass General Brigham
Present
Mass General Brigham
Present
City of Hope National Medical Center
Present

Pediatric Hematology Oncology
Boston Children's Hospital
2011–2014
Pediatrics
Boston Children's Hospital
2008–2011
Harvard Medical School
2004–2008

Research

DICER1 and Associated Conditions: Identification of At-risk Individuals and Recommended Surveillance Strategies
Review · Clinical Cancer Research · 2018 · 285 citations
Comparative evaluation of the antitumor activity of antiangiogenic proteins delivered by gene transfer
Proceedings of the National Academy of Sciences of the United States of America · 2001 · 254 citations
Von Hippel-Lindau and Hereditary Pheochromocytoma/Paraganglioma Syndromes: Clinical Features, Genetics, and Surveillance Recommendations in Childhood
Review · Clinical Cancer Research · 2017 · 192 citations

Lisa Diller
14 papers
KS
Kris Ann Schultz
13 papers
Garrett Brodeur
10 papers
Katherine Janeway
10 papers
Surya Rednam
10 papers
Douglas Stewart
9 papers
JW
Jonathan Wasserman
9 papers
Judy Garber
9 papers
Louis Dehner
9 papers
YM
Yoav Messinger
9 papers
Alanna Church
8 papers
Ashley Hill
8 papers

Clinical trials

Hereditary Risk Factors for Thyroid Cancer
Principal investigator · Recruiting
Dana-Farber Cancer Institute
2016–2029
Testing a Standardized Approach to Surgery and Chemotherapy for Type I Pleuropulmonary Blastoma or the Addition of an Anti-cancer Drug, Topotecan, to the Usual Treatment for Types II and III Pleuropulmonary Blastoma
Site PI · Recruiting · Phase 3
Children's Oncology Group
2025–2029
Targeted Therapy to Increase RAI Uptake in Metastatic DTC
Site PI · Recruiting
Children's Hospital of Philadelphia
2021–2033
Li-Fraumeni & TP53 (LiFT UP): Understanding and Progress
Site PI · Recruiting
Dana-Farber Cancer Institute
2020–2032